Is DuPont profitable in 2026?

DuPont posted a GAAP net loss of roughly $779 million for full year 2025, mostly from separation charges tied to the Qnity spin-off, but operating EBITDA was $1.63 billion and Q1 2026 net sales rose 4% to $1.7 billion, prompting DuPont to raise its 2026 guidance on May 5, 2026.

What is DuPont's biggest risk right now?

Unresolved PFAS litigation is DuPont's dominant risk. Chemours settled a $450 million multi-state federal case on June 24, 2026, but that explicitly excludes DuPont's own liability, and a North Carolina case covering 2,600+ residents was still moving toward settlement with public comment open through July 29, 2026.

Could AI replace DuPont's business?

No. DuPont's core is physical manufacturing of membranes, resins, and protective fabrics like Tyvek, Kevlar, and Nomex under FDA and municipal water-utility certifications. As of its Q4 2025 report, DuPont uses AI only internally to accelerate demand generation, not as a product substitute.

Is DuPont a safe stock to buy in 2026?

DuPont has a regulation-backed moat in healthcare packaging and water technology, which was 47% of 2025 revenue and grew 7% organically at 31.1% EBITDA margin. But its own PFAS liability remains unquantified as of July 2026, creating material valuation uncertainty ahead of August 4, 2026 earnings.

Who owns DuPont now after the spin-offs?

DuPont de Nemours, Inc. trades publicly on the NYSE under ticker DD with no parent company; major holders include institutional investors like BlackRock and Vanguard. It completed a 1-for-3 reverse stock split effective June 24, 2026, cutting authorized shares from about 1.67 billion to 556 million.

What happened to DuPont's electronics business?

DuPont completed the spin-off of its Electronics business as an independent, S&P 500-listed company, Qnity Electronics, Inc. (NYSE: Q), on November 1, 2025. Shareholders received 1 Qnity share for every 2 DuPont shares held, and Qnity launched with more than 10,000 employees across 80 countries.

Manufacturing companies · United States

DuPont

dupont.com ↗

Maker of Tyvek, Kevlar, Nomex, and water filtration membranes for regulated industries.

Defensible for now

Assessed 20 July 2026 · Evidence as of 20 July 2026

Real protection, with named pressure against it.

On the recordSince 20 July 2026 · Checkable from August 4, 2026 · Every call on the record Checkpoint: Q2 2026 earnings and North Carolina PFAS settlement resolution

The call

DuPont's regulated materials business is growing while its industrial side stays weak, with PFAS litigation the real swing factor on the balance sheet.

DuPont is an industrial company that makes specialized packaging and water-treatment products, mostly for hospitals and cities. The company's strongest business (healthcare packaging and water systems) is hard to replace because hospitals and governments have already approved and installed their products, and switching costs are high; 3M and Danaher are rivals in pieces of this market, but DuPont's FDA certifications and existing contracts protect it. The biggest uncertainty is not competition but rather how much money DuPont will have to pay to settle lawsuits over PFAS chemicals, which could reshape the company's value over the next six to twelve months.

Why

AI pressure: None apparent. AI shows up inside DuPont as a demand-generation tool, not as a competitor eating its materials business. Could AI do the core job? Unlikely.

Bigger players: 3M, Danaher/Veralto, and Dow. 3M carries its own PFAS baggage, Veralto pushes into water tech, and Dow pressures commodity-grade industrial materials. Could a giant copy it? No, they are blocked.

What protects it. FDA-certified Tyvek, municipal MemCor water installs, and mil-spec Kevlar/Nomex require regulatory requalification that rivals can't shortcut.

What would change this call

DuPont's Q2 2026 earnings, due August 4, 2026, including PFAS liability disclosures. Shows whether litigation costs are contained or become a larger cash drain.
Outcome of North Carolina PFAS mass-tort settlement after July 29, 2026 comment period. Determines whether DuPont-specific PFAS liability is small and quantified or large and open-ended.
Diversified Industrials segment organic growth in 2026-2027 quarterly reports. Shows whether construction-market weakness persists or stabilizes as guided.

Key numbers

Healthcare & Water: 47% of revenue, +7% organic (FY2025)
Diversified Industrials: 53% of revenue, -2% organic (FY2025)
GAAP net loss $779M on separation charges (FY2025)

Named risks

Unresolved DuPont-specific PFAS liability could exceed $3-4B and constrain cash flow. Severity: high
North Carolina mass-tort settlement outcome pending through July 29, 2026. Severity: high
Diversified Industrials segment (53% of revenue) still declining on construction-market weakness. Severity: medium
GAAP net losses from separation-related and non-cash charges cloud reported profitability. Severity: medium
Reverse stock split and ongoing buybacks may distort per-share metrics near-term. Severity: low

Rivals, as read in July 2026

Rival	Direction	Evidence
3M	contesting	Competes in protective/safety materials; carries over $10B PFAS liabilities as of Dec 2025
Danaher (Veralto)	contesting	Direct water-solutions competitor against DuPont's MemCor and FilmTec lines
Dow	contesting	Diversified Industrials segment fell 2% organically in FY2025 on construction softness
Qnity Electronics	gaining on	Spun off Nov 1, 2025 as independent $30B+ TAM electronics-materials rival
Shin-Etsu Chemical / Fujifilm	contesting	Compete in electronics/imaging materials adjacent to DuPont's advanced materials

Questions people ask

Is DuPont profitable in 2026?: DuPont posted a GAAP net loss of roughly $779 million for full year 2025, mostly from separation charges tied to the Qnity spin-off, but operating EBITDA was $1.63 billion and Q1 2026 net sales rose 4% to $1.7 billion, prompting DuPont to raise its 2026 guidance on May 5, 2026.
What is DuPont's biggest risk right now?: Unresolved PFAS litigation is DuPont's dominant risk. Chemours settled a $450 million multi-state federal case on June 24, 2026, but that explicitly excludes DuPont's own liability, and a North Carolina case covering 2,600+ residents was still moving toward settlement with public comment open through July 29, 2026.
Could AI replace DuPont's business?: No. DuPont's core is physical manufacturing of membranes, resins, and protective fabrics like Tyvek, Kevlar, and Nomex under FDA and municipal water-utility certifications. As of its Q4 2025 report, DuPont uses AI only internally to accelerate demand generation, not as a product substitute.
Is DuPont a safe stock to buy in 2026?: DuPont has a regulation-backed moat in healthcare packaging and water technology, which was 47% of 2025 revenue and grew 7% organically at 31.1% EBITDA margin. But its own PFAS liability remains unquantified as of July 2026, creating material valuation uncertainty ahead of August 4, 2026 earnings.
Who owns DuPont now after the spin-offs?: DuPont de Nemours, Inc. trades publicly on the NYSE under ticker DD with no parent company; major holders include institutional investors like BlackRock and Vanguard. It completed a 1-for-3 reverse stock split effective June 24, 2026, cutting authorized shares from about 1.67 billion to 556 million.
What happened to DuPont's electronics business?: DuPont completed the spin-off of its Electronics business as an independent, S&P 500-listed company, Qnity Electronics, Inc. (NYSE: Q), on November 1, 2025. Shareholders received 1 Qnity share for every 2 DuPont shares held, and Qnity launched with more than 10,000 employees across 80 countries.

Timeline

2026-07-16DuPont launches end-to-end Direct Lithium Extraction portfolio via Water Solutions business
2026-06-24DuPont declares $0.60/share post-split dividend; Chemours settles $450M PFAS case excluding DuPont liability
2026-06-1012 US healthcare manufacturing sites confirmed 100% renewable-electricity powered
2026-06-09DuPont MemCor MBR system selected for Riverstone water facility upgrade, Sydney
2026-05-26DuPont announces 1-for-3 reverse stock split, effective June 24, 2026
2026-05-05Q1 2026 results: $1.7B net sales, up 4%; Aramids sale to Arclin completed April 1, 2026
2026-02-10FY2025 results: $6.8B net sales, $1.63B operating EBITDA, $689M free cash flow
2025-11-06Board approves $2B buyback and new $0.20/share dividend for post-spin DuPont
2025-11-01DuPont completes spin-off of Electronics business as Qnity Electronics (NYSE: Q)

Revision history

20 July 2026

First assessed. Defensible for now. The text above is fixed as of this date and is not edited afterwards.

In the same band

Boeing Vodafone Group LG Electronics